Scipher Medicine rakes in $30 mln Series B

Scipher Medicine, a developer of a molecular technology platform, has raised $30 million in Series B financing.

19 December 2019•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles